ML19345D606

Requests That Cessar Preliminary Design Approval (PDA-2) Be Extended Until NRC Issues Final Design Approval or Application Is Withdrawn.Lack of Approved Ref Design Adds to Uncertainty Facing Util

ML19345D606
Person / Time
Site:	05000470
Issue date:	12/11/1980
From:	Scherer A ABB COMBUSTION ENGINEERING NUCLEAR FUEL (FORMERLY
To:	Eisenhut D Office of Nuclear Reactor Regulation
References
LD-80-072, LD-80-72, NUDOCS 8012160197
Download: ML19345D606 (1)

Text

kWb C-E Power Systems Tel 203/688-1911 Combustion Engmeenng. :nc. Telex 99297 1000 Prospect Hill Road Windsor. Connecticut C6095 POWER H SYSTEMS .

O December 11, 1980~ 2 LD-80-072 1

=ig . . -

-J --

Mr. Darrell G. Eisenhut, Director M e,.  :.

Division of Licensing Id ,, fi Office of Nuclear Reactor Regulation Ul  :

U. S. Nuclear Regulatory Commission Washington, D. C. 20555

Subject:

Combustion Engineering Standard Safety Analysis Report Preliminary Design Approval Extension

Dear Mr. Eisenhut:

The referencability period of the Combustion Engineering (C-E) System 80TM design, as described in CESSAR-PSAR (Docket No. STN 50-470), is due to expire on December 31, 1980. On October 27, 1978, C-E submitted the FSAR version of our System 80 design and it was docketed for the Final Design Approval (FDA) review on December 21, 1979.

As a result, C-E hereby requests that the CESSAR Preliminary Design Approval (PDA-2) be administratively extended and referencable for new CP applicants until either the NRC issues the FDA for CESSAR-FSAR or our application is withdrawn.

When CESSAR-FSAR was submitted more than two years ago, it was expected that an FDA would be issued before the PDA extension period expired. Unfortunately, due to the inability of the NRC to review our application, it has remained essentially idle. Based on the NRC Policy Statement " Statement on Standardization of Nuclear Power Plants," 43 FR 38954, published Aegust 31, 1978 and in order to maintain viability, consistency, and uniformity, the PDA of this application should be con-tinued through to the FDA issuance. Lack of an approved reference design would add to the uncertainty facing a utility as to what the licensing requirements would be and could provide added disincentives to standardization and the nuclear option.

Since CESSAR-FSAR includes all of the information in CESSAR-PSAR, but in even greater detail, and CESSAR-FSG is currently an active application addressing all significant licensing issues, there should be no concern as to the referen: ability of this design.

Due to the timeliness of this issue, your prompt attention to this matter woulo be appreciated.

Very truly yours, COMBUSTION ENGINEERING, INC.

Ed A. E. cherer Director Nuclear Licensing og AES:dac 6 8 someo n 7 A I